The methyl ssobutyl ketone (MIBK) is expected to grow at a CAGR of 3.9% during the forecast period of 2025 to 2033. Methyl isobutyl ketone (MIBK) is a solvent commonly used across various industries due to its outstanding solvency characteristics. MIBK is primarily utilized in surface coatings, rubber chemicals, and the extraction of gold and other precious metals. The chemical serves a critical role in formulations where a high solvent strength is required, including lacquers, varnishes, and paints. Its efficacy in improving the gloss and flow of paints and its compatibility with many different resins make it an invaluable component in the coatings industry.
The plasma surface treatment equipment market is expected to grow at a CAGR of 4.5% during the forecast period of 2025 to 2033. Plasma surface treatment equipment market revolves around technologies used to alter the surface properties of various materials to enhance adhesion, printability, paintability, and coating receptivity. Plasma treatment is a versatile, environmentally friendly process used across a wide range of industries including automotive, electronics, textiles, and healthcare. It involves the use of ionized gases to clean and activate surface areas at a molecular level, without affecting the bulk properties of the materials.
The pelletizing machine market is expected to grow at a CAGR of 3.9% during the forecast period of 2025 to 2033. Pelletizing machine market encompasses a range of equipment used to convert various materials into small, uniform pellets. These machines are crucial in numerous industries, including plastics, pharmaceuticals, animal feed, and biomass. The demand for pelletizing machines is driven by the need for recycling in the plastic industry, the increasing consumption of pelletized feed in animal husbandry, and the growing reliance on biofuels.
The breathable lidding film packaging market is expected to grow at a CAGR of 7.5% during the forecast period of 2025 to 2033. Breathable lidding film packaging refers to a specialized type of packaging film that allows gases like oxygen and carbon dioxide to permeate through, which is essential for maintaining the quality and freshness of perishable goods, particularly food products. These films are typically used to cover trays and containers in applications such as fresh produce, ready meals, and dairy products.
The biotech flavor market is expected to grow at a CAGR of 8.5% during the forecast period of 2025 to 2033. Biotech flavor market refers to the sector of the food and beverage industry that uses biotechnology to develop and produce flavoring agents. This market segment focuses on the creation of flavors through fermentation, enzyme engineering, and tissue culture, among other biotechnological methods.
The laboratory plasticware market is expected to grow at a CAGR of 4.8% during the forecast period of 2025 to 2033. Laboratory plasticware market encompasses a wide range of products designed for use in various laboratory environments, including academic, healthcare, pharmaceutical, and industrial research settings. Plasticware, due to its cost-effectiveness, durability, and flexibility, has become a critical component in laboratories for handling reagents, storing samples, culturing media, and conducting experiments.
The bromobenzene market is expected to grow at a CAGR of 4.4% during the forecast period of 2025 to 2033. Bromobenzene is an aromatic compound extensively utilized in the synthesis of a multitude of other organic substances, including pharmaceuticals, agrochemicals, and various industrial chemicals. The compound serves as a building block in organic chemistry, particularly in the production of phenylmagnesium bromide, a Grignard reagent.
The heat sealable packaging market is expected to grow at a CAGR of 5.1% during the forecast period of 2025 to 2033. Heat sealable packaging refers to a packaging solution that involves using heat to seal packaging materials, creating a tamper-proof and protective barrier. This method is commonly used in various industries, including food and beverage, pharmaceutical, and consumer goods, to enhance product shelf life, maintain product integrity, and ensure safety and hygiene.
The sleeving machines market is expected to grow at a CAGR of 3.6% during the forecast period of 2025 to 2033. Sleeving machines are essential components in packaging lines, particularly in industries such as beverages, food, pharmaceuticals, and personal care. These machines are designed to apply shrink or stretch sleeves around products for labeling, branding, and packaging purposes. The growth of the sleeving machines market is primarily driven by the increasing demand for efficient, automated, and cost-effective packaging solutions that enhance the aesthetic appeal of products and provide tamper evidence.
The Sesame oil market is expected to grow at a CAGR of 6.5% during the forecast period of 2025 to 2033. Sesame oil, derived from sesame seeds, is a highly valued vegetable oil with a rich, nutty flavor and a wide range of culinary and medicinal uses. It is an essential ingredient in various cuisines worldwide, particularly in Asian, Middle Eastern, and African cooking. Sesame oil is also appreciated for its health benefits, including high antioxidant content and heart-healthy fats. The global market for sesame oil has shown robust growth, driven by its rising popularity in cooking, the wellness industry, and its use in various traditional medicines.
The drugs by therapeutic area market covers pharmaceutical products classified according to the diseases and medical conditions they are designed to treat. Major therapeutic areas include oncology, cardiovascular diseases, diabetes and other metabolic disorders, neurological conditions, infectious diseases, respiratory disorders, immunology, gastrointestinal diseases, dermatology, ophthalmology, women’s health and rare diseases. The category includes prescription drugs, generic medicines, biologics, biosimilars, vaccines and advanced therapies.
The wider global pharmaceutical market provides an appropriate benchmark for evaluating growth across therapeutic drug categories. One current industry estimate projects the pharmaceutical market to increase from approximately USD 1.88 trillion in 2026 to USD 3.22 trillion by 2035, representing a compound annual growth rate of 6.15%. North America held the largest regional share in 2025, while Asia-Pacific is expected to demonstrate notable growth through 2035.
Market growth is being supported by the increasing prevalence of chronic and age-related diseases. Rising cases of cancer, diabetes, cardiovascular disorders, arthritis, respiratory diseases and neurological conditions are creating sustained demand for effective treatments. Population ageing, lifestyle changes, urbanization and improved access to diagnosis are further expanding the number of patients receiving long-term therapy.
Oncology remains an important area for pharmaceutical research and commercial investment. Development activity includes targeted therapies, immune checkpoint inhibitors, antibody-drug conjugates, cell therapies and personalized cancer treatments. Diabetes and obesity drugs are also recording strong demand, supported by the wider use of GLP-1 and other metabolic treatments. Neurology research is expanding across Alzheimer’s disease, Parkinson’s disease, epilepsy and mental health conditions.
Biologic drugs and biosimilars represent major market trends. Biologics are increasingly used to treat cancer, autoimmune diseases and rare disorders, while biosimilars can improve access after reference-product patent expiry. Pharmaceutical companies are also developing gene therapies, RNA-based medicines and other advanced treatments for conditions with limited existing options.
Precision medicine is influencing drug development across multiple therapeutic areas. Biomarkers, genomic testing and companion diagnostics help identify patients who are more likely to respond to specific medicines. Artificial intelligence is also being used for target identification, clinical-trial planning and analysis of real-world treatment data.
Market expansion may be restrained by high research costs, lengthy clinical development, regulatory uncertainty and drug-pricing pressure. Patent expirations can reduce revenue for branded products, while safety concerns or unsuccessful clinical trials may delay commercial launches. Access and reimbursement remain major challenges for expensive biologics and advanced therapies.
Acute Market Reports provides therapeutic-area drug research covering product classes, disease indications, routes of administration, distribution channels, company pipelines, competitive conditions and regional opportunities. These reports help pharmaceutical companies, investors, healthcare providers and distributors evaluate treatment demand and growth prospects through 2035.